XIX, COVID Test Kit

  • COVID-19 (SARS-CoV-2) Neutralizing Antibody Test

    XIX, COVID (Sars-Cov-II) se curat ut antibody test

    Anti-antibody test se curat ut Sars, COV-II (Immunochromatography) in vitro, est qualitas quaedam palam facti neutralizing elementorum in Sars, II-Cov aut serum refert, in humana specimina plasma.Et neutralizing elementorum in Sars, II-Cov potest angustos de commercio receptor binding domain glycoprotein in spica positorum virales (RBD) cum angiotensin II-convertens enzyme (Ace2) cell superficiem receptor. Nec deprehendere possum esse ad non incassum antibody in serum et inde commercium RBD plasma qui adversatur, Ace2. In test esse independens-label: et speciei.

  • COVID-19 (SARS-CoV-2) IgG IgM Antibody Test

    XIX, COVID (Sars-Cov-II) Fusobacterium nucleatum antibody test IgM

    XIX, COVID (Corona de Viris Illustribus Morbi), a summa nuper inventa est, ex contagióne morbus effecit, coronavirus.COVID XIX (Sars-Cov-II) Fusobacterium nucleatum / IgM antibody test est CD ad latus fluxus chromatographic inmunoenzimático generalem IgM et palam facti Fusobacterium nucleatum XIX totum humanum sanguinem, per elementorum COVID, serum aut plasma iudicetis.

  • COVID-19 (SARS-CoV-2) Antigen Test

    XIX, COVID (Sars-Cov-II) Expertus Antigen

    Hoc productum qualitas quaedam adhibetur in vitro diffunduntur per homo nasopharyngeal coronavirus noue detecto consilio antigen de obiectis.
    XIX, COVID (Sars-Cov-II) Antigen celeri Test Kit est temptare ac praebet auxilium ad temptatis eventus in in diagnosis de novis coronavirus infectio. Et haec interpretatio quid temptatis, uti eventus Volume Inventiones est etiam confidunt in aliis tum in iudicio professional salutem cura providers. Africa modum test (s) ut confirmet potest considerari in test test eventus hac adeptus.

LXXXVI 15910623759